Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline US Deferred Performance Share Plan notified the Company and the under-mentioned person on 17 April 2013 of the following increase in his interests in American Depositary Shares (ADSs) at a price of $48.52 per ADS following the re-investment of the dividend paid to shareholders on 11 April 2013.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
17 April 2013
